|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 473/16 | (2006.01) |
| C07D 473/34 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/52 | (2006.01) |
| (11) | Number of the document | 2612862 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13150110.8 |
| Date of filing the European patent application | 2005-05-12 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-14 |
| (46) | Date of publication of the claims translation | 2017-01-25 |
| (30) | Number | Date | Country code |
| 570784 P | 2004-05-13 | US |
| (72) |
Fowler, Kerry, W., US
Huang, Danwen, US
Kesicki, Edward, A., US
Ooi, Hua Chee, US
Oliver, Amy, R., US
Ruan, Fuqiang, US
Treiberg, Jennifer, US
Puri, Kamal, Deep, US
|
| (73) |
ICOS CORPORATION,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai |
| Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| Payment date | Validity (years) | Amount | |
| 2024-04-11 | 347.00 EUR |